# Univ Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/univ-biotechnology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.univ-bio.com
- Latest round: Series A (May 7, 2015)
- Investors on record: 1

## About

Based in Shanghai, China and established in 2004, Univ Biotechnology is a biotechnology company that provides antibodies and related products. The company is headquartered in Shanghai, with 32 offices nationwide and 4 domestic sales subsidiaries, with over 500 employees. The company established Nanjing R&D center in 2018, Hangzhou R&D center in 2021, and invested in a GMP-level production center in Nanjing in 2021.

The company focuses on the life sciences, biopharmaceuticals, medical diagnostics, analytical testing and other fields, providing more than 4 million kinds of antibody-based life science reagents, consumables, instruments, software, customization, laboratory services, supply chain services, etc. The company operates a purchase platform that provides guidance on the use of reagents, instrument calibration and machine operation, assist customers in experimental data processing and result analysis, and establish standard operating procedures for experiments.

The revenue of the company in 2020 was 849.08 million and the net income was 76.48 million.

## Funding rounds

- Series A, May 7, 2015 — Step Fund

## Investors

- Step Fund (https://capitalatlas.ai/funds/step-fund) — Series A